GlassScriptPhysician profile
Avery H Nathanson
NPI 1679574198
$6,262.26
in general payments reported to CMS, 2019-2025
36 companies · $16.20 in 2025
The $16.20 reported for 2025 was less than what a typical Sleep Medicine (Internal Medicine) provider received nationally (typical 2025 total: $447).
See the full distribution for Sleep Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,916 · 2020: $547 · 2021: $319 · 2022: $976 · 2023: $1,580 · 2024: $907 · 2025: $16.20.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,503.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,503.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,032.92 | 2019-2024 | Breztri, Fasenra, Airsupra |
| Glaxosmithkline, LLC. | $950.29 | 2019-2024 | Trelegy Ellipta, Nucala, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $495.21 | 2019-2024 | Ofev |
| Jazz Pharmaceuticals INC. | $406.94 | 2019-2024 | |
| Harmony Biosciences LLC | $330.22 | 2020-2024 | Wakix |
| Insmed, INC. | $323.18 | 2019-2024 | Arikayce |
| Regeneron Healthcare Solutions, INC. | $289.96 | 2019-2024 | Dupixent |
| Genzyme Corporation | $289.77 | 2019-2024 | |
| Genentech USA, INC. | $213.43 | 2019-2022 | |
| Inspire Medical Systems, INC. | $187.19 | 2023-2024 | Inspire |
| Mylan Specialty L.P. | $183.76 | 2019-2022 | |
| Grifols USA, LLC | $181.06 | 2019-2024 | Prolastin-C Liquid |
| Amgen INC. | $145.52 | 2023-2024 | Tezspire |
| Actelion Pharmaceuticals US, INC. | $129.66 | 2019-2022 | |
| Paratek Pharmaceuticals, INC. | $126.59 | 2019-2024 | Nuzyra |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $95.01 | 2019-2020 | |
| Circassia INC. | $91.01 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $80.39 | 2020-2023 | Glassia |
| Sunovion Pharmaceuticals INC. | $75.58 | 2019 | |
| Mallinckrodt Enterprises LLC | $70.63 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $68.10 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $66.91 | 2019-2023 | |
| Mallinckrodt Hospital Products INC. | $55.29 | 2023 | Acthar |
| Shire North American Group INC | $48.30 | 2019 | |
| Advanced Respiratory, INC | $41.88 | 2019-2020 | |
| Baxter Healthcare | $41.69 | 2022-2023 | Hillrom - Life 2000 Ventilation System |
| Philips North America LLC | $41.30 | 2019-2024 | (Ak6) Vest Therapy |
| Pulmonx Corporation | $40.97 | 2023-2024 | Chartis Catheter, Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console |
| Electromed, INC. | $30.99 | 2021-2022 | |
| Phadia US INC. | $26.57 | 2022-2024 | Immunocap |
| Vanda Pharmaceuticals INC. | $21.45 | 2023 | Hetlioz |
| Daiichi Sankyo INC. | $19.88 | 2019 | |
| Optinose US, INC. | $18.78 | 2024 | |
| Zoll Respicardia, INC. | $16.20 | 2025 | Remede System |
| Resmed Corp | $14.62 | 2023 | |
| Inogen, INC. | $11.01 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Avery Nathanson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.